Acadia Pharmaceuticals Inc

LMR Partners LLP ACAD

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/16/2020

Shares

27,055

Value ($000)

1,116

Weight

0.0%

2020 Q2 - 2020 Q3 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/16/2020	1,116	0.0%	27,055	9/30/2020
2020 Q2	8/14/2020	1,543	0.0%	31,830	6/30/2020